Coronavirus (COVID-19) resources

Retigabine add-on for refractory partial-onset seizures

To evaluate the efficacy and tolerability of retigabine as an add-on therapy for people with refractory partial onset seizures.

This is a protocol.

You may also be interested in:

Health topics:

Neurology > Epilepsy > Drugs for broad populations

Don't show again

Close

You can help make health evidence easier to understand! No experience or expertise needed, just 30 minutes to volunteer for a study where you will read 2 summaries and answer questions. If interested, click here to provide your email for more information - it will not be used for anything else.